HORIZON program provides recommendations for psoriasis patients with specific joint involvement. Dr. Wayne Gulliver, Chair and Medical Director of NewLab Clinical Research in St, John’s, speaks about the efficacy of IL-17 inhibitors and TNFs for treatment of psoriatic arthritis.
HORIZON program provides recommendations for psoriasis patients with specific joint involvement. Dr. Ron Vender, Regional Chair of the HORIZON Program, speaks about secukinumab in use for scalp psoriasis, nail psoriasis and palmoplantar psoriasis.
New research has linked dupilumab treatment in atopic dermatitis (AD) patients with an increased prevalence of ocular disease when compared to other treatments.
In a new study, researchers have identified the ideal timeline for follow-up phone calls after a patient undergoes Mohs micrographic skin surgery.
A case study of a 13-year-old boy found evidence that acro-ischemia manifesting in the form of lesions on the toes may be a symptom in severe cases of Covid-19. Researchers in Italy investigated the case of a boy, who was observed to have foot lesions on Mar. 8, 2020.
For treatment of acne, black patients appear to be prescribed systemic therapies such as antibiotics at a much lower rate than white patients, according to a new study published online ahead of print in JAMA Dermatology (Feb. 5, 2020).
The discovery of a new RNA molecule could lead to earlier detection of squamous cell carcinoma in the future, according to a new study. The study, published in the American Journal of Pathology (Feb. 2020; 190(2):503-517), found that the molecule, named PRECSIT, is integral in determining how squamous cell carcinoma grows and spreads.
Applied within an hour of mosquito bite, the topical cream imiquimod may reduce the chance of transmission of viral diseases such as Zika and dengue, according to a new study. Researchers of the study, published in Science Translational Medicine (Jan 22, 2020; 12(527)), found that the skin cream, when applied immediately after a mosquito bite, helps to activate immune system response.
Absorption of the active ingredients in four commercially available sunscreens resulted in plasma concentrations that exceed the FDA safety threshold in participants in a new study. Researchers of the study, published in JAMA (Jan 21, 2020; 323(3):256-267) stressed that these findings do not suggest that individuals should stop using sunscreen.
By combining two existing therapies, researchers at the Royal Marsden NHS Foundation Trust in London have found that they have been able to stop or even reverse the progression of advanced melanoma in half of patients. The two therapies, ipilmumab and nivolumab, were tested on patients over the course of five years. The findings were published online ahead of print in the New England Journal of Medicine (Sept. 28, 2019).